# Manipal Health Enterprises

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/manipal-health-enterprises
Canonical HTML page: https://getyourbrief.com/entity/manipal-health-enterprises

## Timeline

- **2026-Q2**: Program Expansion — Expected rollout of enhanced digital post-transplant monitoring for the patient cohort.
- **2026-03-24T09:18:21Z**: Consolidation Phase — Manipal integrates Columbia Asia and AMRI Hospitals into its network.
- **2026-03-24**: IPO Filing — Manipal Health officially files draft papers for an $852 million public listing in India.
- **2026-03-21**: Milestone Announcement — Manipal Hospital Yeshwanthpur officially announces the 500+ transplant achievement.
- **2026-03-12**: World Kidney Day — Global awareness day focusing on kidney health and transplant access.
- **2026**: Clinical Review — Scheduled publication of long-term outcomes for the 50 ABOi transplant cases.
- **2023-04-01**: Temasek Acquisition — Temasek acquires a majority stake in Manipal Health, valuing the firm at $5 billion.

## Recent coverage (5 stories, network-wide)

### Temasek-Backed Manipal Health Files for Landmark Indian Healthcare IPO
2026-03-24 16:57:52 · Sector: startups · Sentiment: Positive · Impact: 6/10 · Sources: 2

Manipal Health Enterprises has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI, marking a significant milestone for the Temasek-backed hospital chain. The IPO is expected to be one of the largest in the Indian healthcare sector, providing a partial exit for institutional investors while fueling further expansion.
Full story: https://getstartupbrief.com/story/manipal-health-enterprises-drhp-ipo-temasek

### Manipal Health Files for $1 Billion IPO as Temasek Eyes Healthcare Dominance
2026-03-24 16:57:19 · Sector: finance · Sentiment: Positive · Impact: 6/10 · Sources: 2

Manipal Health Enterprises has filed its Draft Red Herring Prospectus for a landmark $1 billion initial public offering. The move marks a significant milestone for the Temasek-backed hospital chain, positioning it to capitalize on India's surging demand for private healthcare infrastructure.
Full story: https://getfinancebrief.com/story/manipal-health-enterprises-ipo-temasek

### Manipal Health Files for IPO as Temasek Prepares for Landmark Healthcare Exit
2026-03-24 16:57:15 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

Manipal Health Enterprises has officially filed its Draft Red Herring Prospectus (DRHP) for an initial public offering, marking a pivotal moment for India's second-largest hospital chain. The move follows years of aggressive consolidation and a majority stake acquisition by Singapore’s Temasek.
Full story: https://gethealthbrief.com/story/manipal-health-enterprises-ipo-temasek-drhp

### Temasek-Backed Manipal Health Files for $852M India IPO
2026-03-24 09:18:21 · Sector: finance · Sentiment: Positive · Impact: 7/10 · Sources: 2

Manipal Health Enterprises, India's second-largest hospital chain, has filed for an $852 million initial public offering, marking a major exit opportunity for majority shareholder Temasek. The filing comes amid a surge in Indian equity markets and growing investor appetite for scaled healthcare infrastructure.
Full story: https://getfinancebrief.com/story/manipal-health-india-ipo-temasek

### Manipal Hospital Yeshwanthpur Achieves 500-Kidney Transplant Milestone
2026-03-21 15:17:11 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Manipal Hospital Yeshwanthpur has reached a significant clinical milestone, completing over 500 kidney transplants, including 50 complex ABO-incompatible procedures. This achievement underscores the hospital's leadership in high-acuity nephrology and the expanding capabilities of India's tertiary healthcare sector.
Full story: https://gethealthbrief.com/story/manipal-hospital-yeshwanthpur-500-kidney-transplants-milestone

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.